<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: EHA25Virtual: Pegcetacoplan, a Novel C3 Complement Inhibitor &#8211; Beginning of a new era in the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 	</title>
	<atom:link href="https://www.newpharmaitaly.it/eha25virtual-pegcetacoplan-a-novel-c3-complement-inhibitor-beginning-of-a-new-era-in-the-treatment-of-paroxysmal-nocturnal-hemoglobinuria-pnh/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/eha25virtual-pegcetacoplan-a-novel-c3-complement-inhibitor-beginning-of-a-new-era-in-the-treatment-of-paroxysmal-nocturnal-hemoglobinuria-pnh/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Fri, 12 Jun 2020 04:31:07 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
